On this basis, the authors investigated the potential anticancer effect by silencing the S1PR1 and GP130 genes, through ATMC-NPs containing specific siRNAs; the results obtained in different cancer cell lines, including melanoma B16F10, although in need of further study, have been encouraging [35]. Here, S1PR1 is linked to cancer.